Impact Of Anakinra Use On Clinical Outcomes In Children With Moderate Or Severe Multisystem Inflamma...
Impact Of Anakinra Use On Clinical Outcomes In Children With Moderate Or Severe Multisystem Inflammatory Syndrome In Children: A Propensity Score Matched Retrospective Cohort Study
About this item
Full title
Author / Creator
Publisher
Durham: Research Square
Journal title
Language
English
Formats
Publication information
Publisher
Durham: Research Square
Subjects
More information
Scope and Contents
Contents
BackgroundThe treatment of children with multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 infection involves immunomodulatory therapies such as IVIG and steroids. Anakinra, an interleukin-1 receptor inhibitor, has also been used, but its effectiveness is not established yet. As optimal regimens for MIS-C remain unknown, w...
Alternative Titles
Full title
Impact Of Anakinra Use On Clinical Outcomes In Children With Moderate Or Severe Multisystem Inflammatory Syndrome In Children: A Propensity Score Matched Retrospective Cohort Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2894252186
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2894252186
Other Identifiers
DOI
10.21203/rs.3.rs-3359369/v1
How to access this item
https://www.proquest.com/docview/2894252186?pq-origsite=primo&accountid=13902
